+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid for cystic fibrosis-associated liver disease Final report of a multicenter trial



Ursodeoxycholic acid for cystic fibrosis-associated liver disease Final report of a multicenter trial



Hepatology 18(4 Part 2): 142A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144817

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23(6): 1484-1490, 1996

Ursodeoxycholic acid in cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis 11(1): 72-3; Author Reply 74-75, 2012

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 10: Cd000222, 2012

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 2015(12): Cd000222, 2015

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 2000(2): Cd000222, 2000

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 9: Cd000222, 2017

The effect of ursodeoxycholic acid udca on liver function and bile acid metabolism in patients with cystic fibrosis cf and liver disease. Hepatology 10(4): 726, 1989

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 27(1): 166-174, 1998

Ursodeoxycholic acid treatment in cystic fibrosis related liver disease. Gastroenterology 102(4 Part 2): A862, 1992

Treatment with ursodeoxycholic acid for patients with cystic fibrosis and liver disease. Escobar, H, Baquero, F, Suarez, L International Congress Series; Clinical ecology of cystic fibrosis 275-279, 1993

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. Journal of Pediatrics 117(3): 482-489, 1990

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. Hepatology 39(6): 1673-1682, 2004

Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review. Journal of the Royal Society of Medicine 90(Suppl. 31): 6-12, 1997

Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. Digestive and Liver Disease 42(6): 428-431, 2010

The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. Liver International 27(10): 1402-1408, 2007